GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Price-to-Funds-From-Operations

JWCTF (JW (Cayman) Therapeutics Co) Price-to-Funds-From-Operations : (As of Dec. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


JW (Cayman) Therapeutics Co Business Description

Traded in Other Exchanges
Address
No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.